← Eichor
Study identifier: NCT06034990 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

ICU Fluid Utilization Survey in Southeast Asia

Condition: Critical Illness  ·  Sponsor: Chulalongkorn University

PhaseN/A
Planned participants1000
Who can joinAll sexes, 18 Years to 60 Years
Healthy volunteersYes

About this study

The objective of this study is to examine the use of different types of fluids for resuscitation in different phases of fluid management in 3 types of critically ill patients including (1) not bleeding, not septic but need volume resuscitation (representing normal condition), (2) bleeding but not septic (representing normal vascular integrity but with a loss of intravascular colloids), (3) septic (representing the condition with increase vascular permeability and endothelium damage) in the ICU within Southeast Asia. The data are collected by a 10-min online survey administered to included physicians which will be distributed via multiple online channels through representatives of each countries.

This description comes directly from the study's public registry record.

Talk to the study team

Nattapakorn Mai-on, MD  ·  +66970051116  ·  naphtmaryx@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Chulalongkorn universityBangkok, Bangkok, ThailandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06034990